 | |
| Established | 26 January 2023 |
|---|---|
| Type | Non-departmental public body |
Parent organisation | Department for Science, Innovation and Technology |
| Website | www |
The Advanced Research and Invention Agency, or ARIA, is a research funding agency of the UK government, announced on 19 February 2021 and formally established on 26 January 2023. [1] [2] [3]
The Advanced Research and Invention Agency Act 2022 created the legislative framework for the agency and it was formally established as an independent research body in January 2023. [4]
With a similar remit to that of its US equivalent, DARPA, the agency will fund "high-risk, high-reward" research. [5] [6] Organisationally, it will be small, independent of UKRI (the main UK government funding body), with autonomy to operate at speed innovate funding, (for instance with X-Prize type inducements around research goals), rapid "seed" funding, with successful seeds entering a much smaller tier of large-grants, and bonuses for accomplishing research goals. [7] The agency avoids DARPA’s connection to military research. [8]
As of 2024, the agency's initial budget is confirmed to be £800 million. [9]
Labour Party Member of Parliament Dawn Butler said in March 2021 that the fact ARIA is exempt from Freedom of Information requests would "raise alarm bells" about how taxpayer money is spent, in light of a scandal over how the UK government procured PPE contracts during the Covid-19 pandemic. [10]
On 20 July 2022, the Department for Business, Energy and Industrial Strategy announced that ARIA's first CEO would be Ilan Gur and its first Chair would be Matt Clifford. [11] In early 2023, it was announced that Nobel prize-winning organic chemist Chemistry Sir David MacMillan and Dame Kate Bingham entrepreneur who headed the successful Vaccine Taskforce, would join the board, advancing the high-risk/high-reward research agenda. [12]
The Defense Advanced Research Projects Agency (DARPA) is a research and development agency of the United States Department of Defense responsible for the development of emerging technologies for use by the military. Originally known as the Advanced Research Projects Agency (ARPA), the agency was created on February 7, 1958, by President Dwight D. Eisenhower in response to the Soviet launching of Sputnik 1 in 1957. By collaborating with academia, industry, and government partners, DARPA formulates and executes research and development projects to expand the frontiers of technology and science, often beyond immediate U.S. military requirements. The name of the organization first changed from its founding name, ARPA, to DARPA, in March 1972, changing back to ARPA in February 1993, then reverted to DARPA in March 1996.
The European Medicines Agency (EMA) is an agency of the European Union (EU) in charge of the evaluation and supervision of pharmaceutical products. Prior to 2004, it was known as the European Agency for the Evaluation of Medicinal Products or European Medicines Evaluation Agency (EMEA).
The Medicines and Healthcare products Regulatory Agency (MHRA) is an executive agency of the Department of Health and Social Care in the United Kingdom which is responsible for ensuring that medicines and medical devices work and are acceptably safe.
Semiconductor Research Corporation (SRC), commonly known as SRC, is a high-technology research consortium active in the semiconductor industry. It is a leading semiconductor research consortium. Todd Younkin is the incumbent president and chief executive officer of the company.
EcoHealth Alliance is a US-based non-governmental organization with a stated mission of protecting people, animals, and the environment from emerging infectious diseases. The nonprofit organization focuses on research aimed at preventing pandemics and promoting conservation in hotspot regions worldwide.
The Defence Science and Technology Laboratory (Dstl) is an executive agency of the Ministry of Defence of the United Kingdom. Its stated purpose is "to maximise the impact of science and technology for the defence and security of the UK". The agency is headed by Paul Hollinshead as its chief executive, with the board being chaired by Adrian Belton. Ministerial responsibility lies with the Minister for Defence Procurement.
The Joint Committee on Vaccination and Immunisation (JCVI) is an independent expert advisory committee that advises United Kingdom health departments on immunisation, making recommendations concerning vaccination schedules and vaccine safety. It has a statutory role in England and Wales, and health departments in Scotland and Northern Ireland may choose to accept its advice.
ARPA-E, or Advanced Research Projects Agency–Energy is a United States government agency tasked with promoting and funding research and development of advanced energy technologies. It is modeled after the Defense Advanced Research Projects Agency (DARPA).
The Centre for Process Innovation Limited, trading as CPI, is a British technology and innovation social enterprise covering the agricultural and food technology, energy storage, health technology, materials, and pharmaceutical industry markets, with an emphasis on sustainable solutions and improving healthcare. CPI's headquarters are in Redcar, North Yorkshire. Established in 2004 by the UK Government agency ONE NorthEast, the company was one of five centres of excellence in a long-term strategy to "reposition the North-East [of England] on the world stage for research and development".
The London Institute is Britain's only independent research centre in theoretical physics and mathematics. It was founded to be an alternative to universities, where scientists have to spend time on teaching and administrative duties. Instead, the Institute gives its researchers the freedom and support to devote themselves to research full-time.
UK Research and Innovation (UKRI) is a non-departmental public body of the Government of the United Kingdom that directs research and innovation funding, funded through the science budget of the Department for Science, Innovation and Technology.
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID‑19).
Dame Catherine Elizabeth Bingham is a British venture capitalist. She is a managing partner at a venture capital firm, SV Health Investors. In 2020, Bingham chaired the government's Vaccine Taskforce, steering procurement of vaccines during the COVID-19 pandemic in the United Kingdom.
The COVID-19 vaccination programme in the United Kingdom is an ongoing mass immunisation campaign for coronavirus disease 2019 (COVID-19) during the COVID-19 pandemic in the United Kingdom.
Valneva COVID-19 vaccine is a COVID-19 vaccine developed by French biotechnology company Valneva SE in collaboration with the American biopharmaceutical company Dynavax Technologies.
SARS-CoV-2, the virus that causes COVID-19, was isolated in late 2019. Its genetic sequence was published on 11 January 2020, triggering an urgent international response to prepare for an outbreak and hasten the development of a preventive COVID-19 vaccine. Since 2020, vaccine development has been expedited via unprecedented collaboration in the multinational pharmaceutical industry and between governments. By June 2020, tens of billions of dollars were invested by corporations, governments, international health organizations, and university research groups to develop dozens of vaccine candidates and prepare for global vaccination programs to immunize against COVID‑19 infection. According to the Coalition for Epidemic Preparedness Innovations (CEPI), the geographic distribution of COVID‑19 vaccine development shows North American entities to have about 40% of the activity, compared to 30% in Asia and Australia, 26% in Europe, and a few projects in South America and Africa.
The Advanced Research Projects Agency for Health (ARPA-H) is an agency within the Department of Health and Human Services. Its mission is to "make pivotal investments in break-through technologies and broadly applicable platforms, capabilities, resources, and solutions that have the potential to transform important areas of medicine and health for the benefit of all patients and that cannot readily be accomplished through traditional research or commercial activity."
The Advanced Research and Invention Agency Act 2022 is an act of Parliament of the United Kingdom that creates the Advanced Research and Invention Agency. It was introduced in the House of Commons by the Secretary of State for Business, Energy and Industrial Strategy Kwasi Kwarteng on 2 March 2021.
Ilan Gur is an American chief executive officer and entrepreneur. In 2022 he was appointed as the chief executive officer of the UK's Advanced Research and Invention Agency (ARIA), an independent science funding body.
PsiQuantum, Corp. is an American quantum computing company based in Palo Alto, California. It is developing a general-purpose silicon photonic quantum computer.
